nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—NPPB—blood plasma—bipolar disorder	0.0285	0.0795	CbGeAlD
Carvedilol—SELE—blood plasma—bipolar disorder	0.0193	0.0537	CbGeAlD
Carvedilol—VCAM1—blood plasma—bipolar disorder	0.0177	0.0494	CbGeAlD
Carvedilol—NPPB—adrenal cortex—bipolar disorder	0.0145	0.0404	CbGeAlD
Carvedilol—SELE—adrenal cortex—bipolar disorder	0.00979	0.0273	CbGeAlD
Carvedilol—VCAM1—adrenal cortex—bipolar disorder	0.009	0.0251	CbGeAlD
Carvedilol—HIF1A—adrenal cortex—bipolar disorder	0.00866	0.0241	CbGeAlD
Carvedilol—NPPB—nervous system—bipolar disorder	0.00849	0.0236	CbGeAlD
Carvedilol—GJA1—adrenal cortex—bipolar disorder	0.0084	0.0234	CbGeAlD
Carvedilol—CYP1A2—urine—bipolar disorder	0.00777	0.0216	CbGeAlD
Carvedilol—CYP2C9—urine—bipolar disorder	0.00738	0.0205	CbGeAlD
Carvedilol—NDUFC2—adrenal cortex—bipolar disorder	0.00731	0.0204	CbGeAlD
Carvedilol—CYP2E1—urine—bipolar disorder	0.00699	0.0195	CbGeAlD
Carvedilol—SELE—thyroid gland—bipolar disorder	0.00682	0.019	CbGeAlD
Carvedilol—VEGFA—adrenal cortex—bipolar disorder	0.00663	0.0185	CbGeAlD
Carvedilol—NPPB—brain—bipolar disorder	0.00649	0.0181	CbGeAlD
Carvedilol—VCAM1—thyroid gland—bipolar disorder	0.00627	0.0175	CbGeAlD
Carvedilol—HIF1A—thyroid gland—bipolar disorder	0.00603	0.0168	CbGeAlD
Carvedilol—GJA1—thyroid gland—bipolar disorder	0.00585	0.0163	CbGeAlD
Carvedilol—SELE—nervous system—bipolar disorder	0.00573	0.016	CbGeAlD
Carvedilol—CYP3A4—urine—bipolar disorder	0.00562	0.0157	CbGeAlD
Carvedilol—CYP2D6—urine—bipolar disorder	0.00553	0.0154	CbGeAlD
Carvedilol—SELE—cerebellum—bipolar disorder	0.0054	0.015	CbGeAlD
Carvedilol—VCAM1—nervous system—bipolar disorder	0.00527	0.0147	CbGeAlD
Carvedilol—NDUFC2—thyroid gland—bipolar disorder	0.00509	0.0142	CbGeAlD
Carvedilol—HIF1A—nervous system—bipolar disorder	0.00507	0.0141	CbGeAlD
Carvedilol—GJA1—nervous system—bipolar disorder	0.00492	0.0137	CbGeAlD
Carvedilol—HIF1A—cerebellum—bipolar disorder	0.00477	0.0133	CbGeAlD
Carvedilol—GJA1—cerebellum—bipolar disorder	0.00463	0.0129	CbGeAlD
Carvedilol—VEGFA—thyroid gland—bipolar disorder	0.00462	0.0129	CbGeAlD
Carvedilol—SELE—brain—bipolar disorder	0.00438	0.0122	CbGeAlD
Carvedilol—Tamsulosin—DRD3—bipolar disorder	0.00433	0.272	CrCbGaD
Carvedilol—NDUFC2—nervous system—bipolar disorder	0.00428	0.0119	CbGeAlD
Carvedilol—CYP1A2—blood plasma—bipolar disorder	0.00405	0.0113	CbGeAlD
Carvedilol—NDUFC2—cerebellum—bipolar disorder	0.00403	0.0112	CbGeAlD
Carvedilol—VCAM1—brain—bipolar disorder	0.00403	0.0112	CbGeAlD
Carvedilol—HIF1A—brain—bipolar disorder	0.00388	0.0108	CbGeAlD
Carvedilol—CYP2C9—blood plasma—bipolar disorder	0.00385	0.0107	CbGeAlD
Carvedilol—GJA1—brain—bipolar disorder	0.00376	0.0105	CbGeAlD
Carvedilol—ADRA2A—blood plasma—bipolar disorder	0.00373	0.0104	CbGeAlD
Carvedilol—Bopindolol—HTR1A—bipolar disorder	0.00367	0.231	CrCbGaD
Carvedilol—VEGFA—cerebellum—bipolar disorder	0.00366	0.0102	CbGeAlD
Carvedilol—CYP2E1—blood plasma—bipolar disorder	0.00365	0.0102	CbGeAlD
Carvedilol—Tamsulosin—HTR1A—bipolar disorder	0.00353	0.222	CrCbGaD
Carvedilol—PTGS1—blood plasma—bipolar disorder	0.00351	0.00979	CbGeAlD
Carvedilol—NDUFC2—brain—bipolar disorder	0.00327	0.00912	CbGeAlD
Carvedilol—Tamsulosin—DRD2—bipolar disorder	0.003	0.188	CrCbGaD
Carvedilol—VEGFA—brain—bipolar disorder	0.00297	0.00828	CbGeAlD
Carvedilol—CYP3A4—blood plasma—bipolar disorder	0.00293	0.00818	CbGeAlD
Carvedilol—CYP2D6—blood plasma—bipolar disorder	0.00289	0.00805	CbGeAlD
Carvedilol—ADRA1B—nervous system—bipolar disorder	0.0026	0.00723	CbGeAlD
Carvedilol—ADRA1D—nervous system—bipolar disorder	0.00254	0.00707	CbGeAlD
Carvedilol—ADRA2C—adrenal cortex—bipolar disorder	0.00237	0.00661	CbGeAlD
Carvedilol—ABCB1—blood plasma—bipolar disorder	0.00208	0.00579	CbGeAlD
Carvedilol—ADRA1B—brain—bipolar disorder	0.00198	0.00553	CbGeAlD
Carvedilol—ADRA1D—brain—bipolar disorder	0.00194	0.00541	CbGeAlD
Carvedilol—ADRB1—nervous system—bipolar disorder	0.00184	0.00514	CbGeAlD
Carvedilol—ADRA1A—nervous system—bipolar disorder	0.00146	0.00406	CbGeAlD
Carvedilol—CYP1A2—thyroid gland—bipolar disorder	0.00143	0.00399	CbGeAlD
Carvedilol—CYP1A1—thyroid gland—bipolar disorder	0.00141	0.00394	CbGeAlD
Carvedilol—ADRB1—brain—bipolar disorder	0.00141	0.00393	CbGeAlD
Carvedilol—KCNH2—nervous system—bipolar disorder	0.00141	0.00392	CbGeAlD
Carvedilol—ADRA2C—nervous system—bipolar disorder	0.00139	0.00387	CbGeAlD
Carvedilol—Propranolol—HTR1A—bipolar disorder	0.00138	0.0865	CrCbGaD
Carvedilol—ADRA1A—cerebellum—bipolar disorder	0.00137	0.00382	CbGeAlD
Carvedilol—KCNH2—cerebellum—bipolar disorder	0.00133	0.00369	CbGeAlD
Carvedilol—ADRA2A—thyroid gland—bipolar disorder	0.00132	0.00367	CbGeAlD
Carvedilol—ADRA2C—cerebellum—bipolar disorder	0.00131	0.00364	CbGeAlD
Carvedilol—CYP2E1—thyroid gland—bipolar disorder	0.00129	0.00359	CbGeAlD
Carvedilol—PTGS1—thyroid gland—bipolar disorder	0.00124	0.00346	CbGeAlD
Carvedilol—CYP1A1—nervous system—bipolar disorder	0.00119	0.00331	CbGeAlD
Carvedilol—ADRA1A—brain—bipolar disorder	0.00111	0.00311	CbGeAlD
Carvedilol—ADRA2A—nervous system—bipolar disorder	0.00111	0.00309	CbGeAlD
Carvedilol—CYP2E1—nervous system—bipolar disorder	0.00108	0.00302	CbGeAlD
Carvedilol—KCNH2—brain—bipolar disorder	0.00108	0.003	CbGeAlD
Carvedilol—ADRA2C—brain—bipolar disorder	0.00106	0.00296	CbGeAlD
Carvedilol—ABCB1—adrenal cortex—bipolar disorder	0.00105	0.00294	CbGeAlD
Carvedilol—PTGS1—nervous system—bipolar disorder	0.00105	0.00291	CbGeAlD
Carvedilol—ADRA2A—cerebellum—bipolar disorder	0.00104	0.00291	CbGeAlD
Carvedilol—CYP2E1—cerebellum—bipolar disorder	0.00102	0.00284	CbGeAlD
Carvedilol—CYP1A1—brain—bipolar disorder	0.000909	0.00253	CbGeAlD
Carvedilol—CYP3A4—nervous system—bipolar disorder	0.000873	0.00243	CbGeAlD
Carvedilol—CYP2D6—nervous system—bipolar disorder	0.000859	0.00239	CbGeAlD
Carvedilol—ADRA2A—brain—bipolar disorder	0.000848	0.00236	CbGeAlD
Carvedilol—CYP2E1—brain—bipolar disorder	0.000829	0.00231	CbGeAlD
Carvedilol—CYP2D6—cerebellum—bipolar disorder	0.000808	0.00225	CbGeAlD
Carvedilol—PTGS1—brain—bipolar disorder	0.000799	0.00223	CbGeAlD
Carvedilol—ABCB1—thyroid gland—bipolar disorder	0.000735	0.00205	CbGeAlD
Carvedilol—CYP2D6—brain—bipolar disorder	0.000657	0.00183	CbGeAlD
Carvedilol—ABCB1—nervous system—bipolar disorder	0.000618	0.00172	CbGeAlD
Carvedilol—ABCB1—cerebellum—bipolar disorder	0.000581	0.00162	CbGeAlD
Carvedilol—ABCB1—brain—bipolar disorder	0.000472	0.00132	CbGeAlD
Carvedilol—ADRA2A—Signaling Pathways—PDE4B—bipolar disorder	3.85e-05	6.16e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—NR1D1—bipolar disorder	3.85e-05	6.16e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—DRD4—bipolar disorder	3.85e-05	6.16e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—DRD4—bipolar disorder	3.81e-05	6.1e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TAC1—bipolar disorder	3.8e-05	6.08e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—DRD1—bipolar disorder	3.79e-05	6.06e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—HTR2C—bipolar disorder	3.79e-05	6.06e-05	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—HTR2A—bipolar disorder	3.79e-05	6.06e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PIK3C2A—bipolar disorder	3.77e-05	6.03e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—DRD4—bipolar disorder	3.76e-05	6.02e-05	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—POMC—bipolar disorder	3.74e-05	5.98e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—DRD1—bipolar disorder	3.73e-05	5.96e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—HTR2C—bipolar disorder	3.73e-05	5.96e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—POMC—bipolar disorder	3.73e-05	5.96e-05	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—POMC—bipolar disorder	3.7e-05	5.92e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NTRK2—bipolar disorder	3.68e-05	5.89e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—NCAN—bipolar disorder	3.68e-05	5.89e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—SNAP25—bipolar disorder	3.68e-05	5.89e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—DRD3—bipolar disorder	3.67e-05	5.87e-05	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—POMC—bipolar disorder	3.66e-05	5.85e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—GSK3A—bipolar disorder	3.65e-05	5.84e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—CACNA1C—bipolar disorder	3.64e-05	5.83e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NTRK2—bipolar disorder	3.63e-05	5.8e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—ADCY2—bipolar disorder	3.62e-05	5.79e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—DRD3—bipolar disorder	3.61e-05	5.78e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TCF7L2—bipolar disorder	3.61e-05	5.77e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—SLC5A3—bipolar disorder	3.61e-05	5.77e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—GSK3A—bipolar disorder	3.59e-05	5.75e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—ADCY2—bipolar disorder	3.59e-05	5.74e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—DRD2—bipolar disorder	3.58e-05	5.73e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TCF7L2—bipolar disorder	3.58e-05	5.72e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—NTRK1—bipolar disorder	3.56e-05	5.7e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—DRD4—bipolar disorder	3.56e-05	5.7e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—DRD2—bipolar disorder	3.55e-05	5.68e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PIK3C2A—bipolar disorder	3.55e-05	5.68e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—ADCY2—bipolar disorder	3.54e-05	5.67e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TCF7L2—bipolar disorder	3.53e-05	5.65e-05	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—HTR2A—bipolar disorder	3.52e-05	5.63e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—DRD2—bipolar disorder	3.51e-05	5.61e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—DRD4—bipolar disorder	3.51e-05	5.61e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	3.5e-05	5.61e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—S100B—bipolar disorder	3.46e-05	5.54e-05	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—POMC—bipolar disorder	3.46e-05	5.53e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—HTR2A—bipolar disorder	3.44e-05	5.5e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—COMT—bipolar disorder	3.43e-05	5.49e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—HTR1A—bipolar disorder	3.43e-05	5.48e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—COMT—bipolar disorder	3.43e-05	5.48e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NDUFV2—bipolar disorder	3.41e-05	5.46e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—MAOA—bipolar disorder	3.41e-05	5.45e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—GSK3B—bipolar disorder	3.41e-05	5.45e-05	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—POMC—bipolar disorder	3.4e-05	5.45e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—MAOA—bipolar disorder	3.4e-05	5.44e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—GSK3B—bipolar disorder	3.4e-05	5.44e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—POMC—bipolar disorder	3.39e-05	5.43e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—SNAP25—bipolar disorder	3.38e-05	5.41e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—POMC—bipolar disorder	3.38e-05	5.4e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TAC1—bipolar disorder	3.38e-05	5.4e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—POMC—bipolar disorder	3.37e-05	5.39e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—POMC—bipolar disorder	3.36e-05	5.38e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—INS—bipolar disorder	3.36e-05	5.37e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—ADCY2—bipolar disorder	3.35e-05	5.36e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—INS—bipolar disorder	3.35e-05	5.36e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TCF7L2—bipolar disorder	3.34e-05	5.34e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—POMC—bipolar disorder	3.32e-05	5.31e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—DRD2—bipolar disorder	3.32e-05	5.31e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—HTR2C—bipolar disorder	3.31e-05	5.3e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—DRD1—bipolar disorder	3.31e-05	5.3e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—AKR1C4—bipolar disorder	3.31e-05	5.29e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—ADCY2—bipolar disorder	3.3e-05	5.28e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TCF7L2—bipolar disorder	3.29e-05	5.26e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CLOCK—bipolar disorder	3.27e-05	5.22e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—DRD2—bipolar disorder	3.27e-05	5.22e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—ADCY2—bipolar disorder	3.26e-05	5.21e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—NTRK1—bipolar disorder	3.25e-05	5.19e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NTRK2—bipolar disorder	3.22e-05	5.15e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—NTRK1—bipolar disorder	3.22e-05	5.14e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—DRD3—bipolar disorder	3.21e-05	5.13e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—HTR2A—bipolar disorder	3.19e-05	5.11e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—GSK3A—bipolar disorder	3.19e-05	5.11e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—HTR1A—bipolar disorder	3.19e-05	5.1e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—SNAP25—bipolar disorder	3.19e-05	5.1e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—TPH2—bipolar disorder	3.18e-05	5.09e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—TSHB—bipolar disorder	3.18e-05	5.09e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CACNB2—bipolar disorder	3.18e-05	5.09e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—NTRK1—bipolar disorder	3.17e-05	5.08e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—S100B—bipolar disorder	3.15e-05	5.05e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—POMC—bipolar disorder	3.14e-05	5.03e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TAC1—bipolar disorder	3.14e-05	5.02e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—DPYD—bipolar disorder	3.13e-05	5.01e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—S100B—bipolar disorder	3.13e-05	5e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—DRD4—bipolar disorder	3.11e-05	4.98e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—POMC—bipolar disorder	3.09e-05	4.95e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—S100B—bipolar disorder	3.09e-05	4.94e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CLOCK—bipolar disorder	3.08e-05	4.92e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—DRD1—bipolar disorder	3.08e-05	4.92e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—HTR2C—bipolar disorder	3.08e-05	4.92e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—NRG1—bipolar disorder	3.06e-05	4.89e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CLOCK—bipolar disorder	3.05e-05	4.88e-05	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—POMC—bipolar disorder	3.02e-05	4.84e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NTRK1—bipolar disorder	3e-05	4.81e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—TSHB—bipolar disorder	3e-05	4.8e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—TPH2—bipolar disorder	3e-05	4.8e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CACNB2—bipolar disorder	3e-05	4.8e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NTRK2—bipolar disorder	2.99e-05	4.79e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—ADCY2—bipolar disorder	2.99e-05	4.78e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—DRD3—bipolar disorder	2.98e-05	4.77e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—TPH2—bipolar disorder	2.97e-05	4.76e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CACNB2—bipolar disorder	2.97e-05	4.76e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—TSHB—bipolar disorder	2.97e-05	4.76e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NR1D1—bipolar disorder	2.97e-05	4.75e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—GSK3A—bipolar disorder	2.97e-05	4.75e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NTRK1—bipolar disorder	2.96e-05	4.73e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—DPYD—bipolar disorder	2.95e-05	4.72e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—ADCY2—bipolar disorder	2.93e-05	4.69e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—DPYD—bipolar disorder	2.93e-05	4.68e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TCF7L2—bipolar disorder	2.92e-05	4.67e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—S100B—bipolar disorder	2.92e-05	4.67e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CACNA1C—bipolar disorder	2.91e-05	4.66e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—DRD2—bipolar disorder	2.9e-05	4.64e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—DRD4—bipolar disorder	2.89e-05	4.63e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—S100B—bipolar disorder	2.87e-05	4.6e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NCAN—bipolar disorder	2.84e-05	4.54e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PIK3C2A—bipolar disorder	2.84e-05	4.54e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—ADCY2—bipolar disorder	2.82e-05	4.51e-05	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—POMC—bipolar disorder	2.81e-05	4.5e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—COMT—bipolar disorder	2.79e-05	4.46e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—NRG1—bipolar disorder	2.78e-05	4.45e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SLC5A3—bipolar disorder	2.78e-05	4.45e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—MTHFR—bipolar disorder	2.78e-05	4.44e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—MTHFR—bipolar disorder	2.77e-05	4.43e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—MAOA—bipolar disorder	2.77e-05	4.43e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—NRG1—bipolar disorder	2.76e-05	4.41e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—HTR2A—bipolar disorder	2.76e-05	4.41e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—POMC—bipolar disorder	2.75e-05	4.39e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CACNA1C—bipolar disorder	2.74e-05	4.39e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—NRG1—bipolar disorder	2.72e-05	4.36e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—ADCY2—bipolar disorder	2.72e-05	4.36e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CACNA1C—bipolar disorder	2.72e-05	4.35e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TCF7L2—bipolar disorder	2.71e-05	4.34e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—DRD2—bipolar disorder	2.69e-05	4.31e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	2.67e-05	4.28e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	2.65e-05	4.24e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NTRK1—bipolar disorder	2.63e-05	4.2e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	2.61e-05	4.18e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CLOCK—bipolar disorder	2.61e-05	4.17e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NRG1—bipolar disorder	2.58e-05	4.12e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—COMT—bipolar disorder	2.56e-05	4.1e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—S100B—bipolar disorder	2.55e-05	4.08e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—POMC—bipolar disorder	2.55e-05	4.08e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—SNAP25—bipolar disorder	2.54e-05	4.07e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—MAOA—bipolar disorder	2.54e-05	4.07e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—TPH2—bipolar disorder	2.54e-05	4.06e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CACNB2—bipolar disorder	2.54e-05	4.06e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—TSHB—bipolar disorder	2.54e-05	4.06e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NRG1—bipolar disorder	2.54e-05	4.06e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—HTR2A—bipolar disorder	2.51e-05	4.02e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—DPYD—bipolar disorder	2.5e-05	4e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—HTR2A—bipolar disorder	2.49e-05	3.98e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—HTR2A—bipolar disorder	2.46e-05	3.93e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NTRK1—bipolar disorder	2.44e-05	3.9e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—COMT—bipolar disorder	2.41e-05	3.86e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—SNAP25—bipolar disorder	2.4e-05	3.84e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—MAOA—bipolar disorder	2.4e-05	3.83e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—SNAP25—bipolar disorder	2.38e-05	3.8e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—S100B—bipolar disorder	2.37e-05	3.79e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CACNA1C—bipolar disorder	2.32e-05	3.72e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—HTR2A—bipolar disorder	2.32e-05	3.72e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—HTR2A—bipolar disorder	2.29e-05	3.66e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	2.26e-05	3.62e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—MTHFR—bipolar disorder	2.25e-05	3.61e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NRG1—bipolar disorder	2.25e-05	3.6e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—ADCY2—bipolar disorder	2.25e-05	3.6e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	2.23e-05	3.57e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—POMC—bipolar disorder	2.22e-05	3.55e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—GSK3B—bipolar disorder	2.22e-05	3.55e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—POMC—bipolar disorder	2.22e-05	3.54e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—INS—bipolar disorder	2.21e-05	3.53e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—INS—bipolar disorder	2.2e-05	3.52e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—POMC—bipolar disorder	2.2e-05	3.52e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—INS—bipolar disorder	2.19e-05	3.5e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ADCY2—bipolar disorder	2.12e-05	3.39e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ADCY2—bipolar disorder	2.1e-05	3.37e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NRG1—bipolar disorder	2.09e-05	3.35e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—MTHFR—bipolar disorder	2.07e-05	3.31e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—HTR2A—bipolar disorder	2.03e-05	3.25e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—SNAP25—bipolar disorder	2.03e-05	3.25e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—GSK3B—bipolar disorder	2.02e-05	3.23e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CLOCK—bipolar disorder	2.01e-05	3.22e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—POMC—bipolar disorder	2.01e-05	3.21e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—GSK3B—bipolar disorder	2e-05	3.2e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—INS—bipolar disorder	1.99e-05	3.19e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—POMC—bipolar disorder	1.99e-05	3.18e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—GSK3B—bipolar disorder	1.98e-05	3.16e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—INS—bipolar disorder	1.98e-05	3.16e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—POMC—bipolar disorder	1.96e-05	3.14e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—TPH2—bipolar disorder	1.96e-05	3.14e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—TSHB—bipolar disorder	1.96e-05	3.14e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CACNB2—bipolar disorder	1.96e-05	3.14e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—MTHFR—bipolar disorder	1.95e-05	3.12e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—INS—bipolar disorder	1.95e-05	3.12e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—DPYD—bipolar disorder	1.93e-05	3.09e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—COMT—bipolar disorder	1.93e-05	3.08e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—MAOA—bipolar disorder	1.91e-05	3.06e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—HTR2A—bipolar disorder	1.89e-05	3.02e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—GSK3B—bipolar disorder	1.87e-05	2.99e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—POMC—bipolar disorder	1.86e-05	2.97e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—INS—bipolar disorder	1.85e-05	2.95e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—GSK3B—bipolar disorder	1.84e-05	2.95e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—POMC—bipolar disorder	1.83e-05	2.92e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—COMT—bipolar disorder	1.82e-05	2.91e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—INS—bipolar disorder	1.82e-05	2.91e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—MAOA—bipolar disorder	1.8e-05	2.89e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—POMC—bipolar disorder	1.8e-05	2.88e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—COMT—bipolar disorder	1.8e-05	2.88e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ADCY2—bipolar disorder	1.8e-05	2.88e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CACNA1C—bipolar disorder	1.79e-05	2.87e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—INS—bipolar disorder	1.79e-05	2.87e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—MAOA—bipolar disorder	1.79e-05	2.86e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	1.75e-05	2.8e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—POMC—bipolar disorder	1.66e-05	2.65e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—INS—bipolar disorder	1.65e-05	2.63e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—GSK3B—bipolar disorder	1.64e-05	2.62e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—POMC—bipolar disorder	1.62e-05	2.6e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—INS—bipolar disorder	1.61e-05	2.58e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SNAP25—bipolar disorder	1.57e-05	2.51e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—POMC—bipolar disorder	1.56e-05	2.5e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—MTHFR—bipolar disorder	1.56e-05	2.49e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—INS—bipolar disorder	1.55e-05	2.48e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—COMT—bipolar disorder	1.54e-05	2.46e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—MAOA—bipolar disorder	1.53e-05	2.45e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—GSK3B—bipolar disorder	1.52e-05	2.43e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—POMC—bipolar disorder	1.51e-05	2.41e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—INS—bipolar disorder	1.5e-05	2.4e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—MTHFR—bipolar disorder	1.47e-05	2.35e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—MTHFR—bipolar disorder	1.46e-05	2.33e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ADCY2—bipolar disorder	1.39e-05	2.22e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—POMC—bipolar disorder	1.25e-05	1.99e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—MTHFR—bipolar disorder	1.24e-05	1.99e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—INS—bipolar disorder	1.24e-05	1.98e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—COMT—bipolar disorder	1.19e-05	1.9e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—MAOA—bipolar disorder	1.18e-05	1.89e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—POMC—bipolar disorder	1.17e-05	1.88e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—INS—bipolar disorder	1.17e-05	1.87e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—POMC—bipolar disorder	1.16e-05	1.86e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—INS—bipolar disorder	1.16e-05	1.85e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—POMC—bipolar disorder	9.95e-06	1.59e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—INS—bipolar disorder	9.9e-06	1.58e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—MTHFR—bipolar disorder	9.6e-06	1.54e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—POMC—bipolar disorder	7.68e-06	1.23e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—INS—bipolar disorder	7.64e-06	1.22e-05	CbGpPWpGaD
